Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections - PubMed (original) (raw)

Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections

R Colombari et al. Virchows Arch A Pathol Anat Histopathol. 1988.

Abstract

The distribution of a recently produced melanoma specific antibody (HMB-45) has been evaluated histochemically on paraffin sections in a large panel of melanocytic and non melanocytic tumours. Results have been compared with the presence of S-100 protein. HMB-45 was shown to be a highly specific antibody being present only in melanomas, junctional melanocytes and histogenetically related neoplasms such as melanocytic neuroectodermal tumour of infancy and, at low levels, on a proportion of peripheral nerve sheath tumours. The high specificity of HMB-45 antibody, coupled with the greater sensitivity of S-100, makes the combined use of these markers practical in the differential diagnosis of skin tumours and of metastatic lesions of uncertain primary site.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Semin Oncol. 1975 Jun;2(2):119-47 - PubMed
    1. Adv Morphog. 1970;8:41-114 - PubMed
    1. Br J Cancer. 1986 Jun;53(6):839-41 - PubMed
    1. Am J Clin Pathol. 1986 Feb;85(2):160-8 - PubMed
    1. Am J Surg Pathol. 1984 Sep;8(9):645-53 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources